Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Biomedicines|August 27, 2021
Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective StudyFederica Lessi, Marica Laurino, Cristina Papayannidis, et al.
Cancer Reports (Hoboken, N.J.)|April 25, 2024
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patientsBianca Serio, Francesco Grimaldi, Lucia Ammirati, et al.
Cancer Medicine|April 19, 2019
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosisNovella Pugliese, Claudia Giordano, Davide Nappi, et al.
International Journal of Molecular Sciences|December 11, 2019
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive LeukemiasStefania Stella, Enrico Marco Gottardi, Valeria Favout, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2016
Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T CellsFrancesco Grimaldi, Victoria Potter, Pilar Perez-Abellan, et al.
Haematologica|April 9, 2026
Disease course of FLT3 mutated extramedullary acute myeloid leukemia and efficacy of gilteritinibFrancesco Angotzi, Erika Borlenghi, Chiara Sartor, et al.
Cancers|May 11, 2024
Deregulation of New Cell Death Mechanisms in LeukemiaGregorio Favale, Federica Donnarumma, Vincenza Capone, et al.
Blood Advances|October 25, 2019
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 yearsVipul Sharad Sheth, Victoria Potter, Shreyans A Gandhi, et al.
Pageof 6